Literature DB >> 24686062

Vibrio cholerae-induced inflammation in the neonatal mouse cholera model.

Anne L Bishop1, Bharathi Patimalla, Andrew Camilli.   

Abstract

Vibrio cholerae is the causative agent of the acute diarrheal disease of cholera. Innate immune responses to V. cholerae are not a major cause of cholera pathology, which is characterized by severe, watery diarrhea induced by the action of cholera toxin. Innate responses may, however, contribute to resolution of infection and must be required to initiate adaptive responses after natural infection and oral vaccination. Here we investigated whether a well-established infant mouse model of cholera can be used to observe an innate immune response. We also used a vaccination model in which immunized dams protect their pups from infection through breast milk antibodies to investigate innate immune responses after V. cholerae infection for pups suckled by an immune dam. At the peak of infection, we observed neutrophil recruitment accompanied by induction of KC, macrophage inflammatory protein 2 (MIP-2), NOS-2, interleukin-6 (IL-6), and IL-17a. Pups suckled by an immunized dam did not mount this response. Accessory toxins RtxA and HlyA played no discernible role in neutrophil recruitment in a wild-type background. The innate response to V. cholerae deleted for cholera toxin-encoding phage (CTX) and part of rtxA was significantly reduced, suggesting a role for CTX-carried genes or for RtxA in the absence of cholera toxin (CTX). Two extracellular V. cholerae DNases were not required for neutrophil recruitment, but DNase-deficient V. cholerae caused more clouds of DNA in the intestinal lumen, which appeared to be neutrophil extracellular traps (NETs), suggesting that V. cholerae DNases combat NETs. Thus, the infant mouse model has hitherto unrecognized utility for interrogating innate responses to V. cholerae infection.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24686062      PMCID: PMC4019157          DOI: 10.1128/IAI.00054-14

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  81 in total

1.  Mucosal administration of flagellin protects mice from Streptococcus pneumoniae lung infection.

Authors:  Natalia Muñoz; Laurye Van Maele; Juan M Marqués; Analía Rial; Jean-Claude Sirard; José A Chabalgoity
Journal:  Infect Immun       Date:  2010-07-19       Impact factor: 3.441

2.  Developmental expression of two CXC chemokines, MIP-2 and KC, and their receptors.

Authors:  J Luan; Y Furuta; J Du; A Richmond
Journal:  Cytokine       Date:  2001-06-07       Impact factor: 3.861

3.  Mucosal immunization with Vibrio cholerae outer membrane vesicles provides maternal protection mediated by antilipopolysaccharide antibodies that inhibit bacterial motility.

Authors:  Anne L Bishop; Stefan Schild; Bharathi Patimalla; Brian Klein; Andrew Camilli
Journal:  Infect Immun       Date:  2010-08-02       Impact factor: 3.441

4.  Hyperinfectivity of human-passaged Vibrio cholerae can be modeled by growth in the infant mouse.

Authors:  Ashfaqul Alam; Regina C Larocque; Jason B Harris; Cecily Vanderspurt; Edward T Ryan; Firdausi Qadri; Stephen B Calderwood
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

5.  Ultrastructural changes in the upper small intestinal mucosa in patients with cholera.

Authors:  M M Mathan; G Chandy; V I Mathan
Journal:  Gastroenterology       Date:  1995-08       Impact factor: 22.682

6.  Acute dehydrating disease caused by Vibrio cholerae serogroups O1 and O139 induce increases in innate cells and inflammatory mediators at the mucosal surface of the gut.

Authors:  F Qadri; T R Bhuiyan; K K Dutta; R Raqib; M S Alam; N H Alam; A-M Svennerholm; M M Mathan
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

7.  Complexity of rice-water stool from patients with Vibrio cholerae plays a role in the transmission of infectious diarrhea.

Authors:  Eric J Nelson; Ashrafuzzaman Chowdhury; Jason B Harris; Yasmin A Begum; Fahima Chowdhury; Ashraful I Khan; Regina C Larocque; Anne L Bishop; Edward T Ryan; Andrew Camilli; Firdausi Qadri; Stephen B Calderwood
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-16       Impact factor: 11.205

8.  Decreased potency of the Vibrio cholerae sheathed flagellum to trigger host innate immunity.

Authors:  Sang Sun Yoon; John J Mekalanos
Journal:  Infect Immun       Date:  2008-01-03       Impact factor: 3.441

9.  Identification of toxS, a regulatory gene whose product enhances toxR-mediated activation of the cholera toxin promoter.

Authors:  V L Miller; V J DiRita; J J Mekalanos
Journal:  J Bacteriol       Date:  1989-03       Impact factor: 3.490

10.  Back to the future: studying cholera pathogenesis using infant rabbits.

Authors:  Jennifer M Ritchie; Haopeng Rui; Roderick T Bronson; Matthew K Waldor
Journal:  MBio       Date:  2010-05-18       Impact factor: 7.867

View more
  12 in total

1.  Monoclonal antibodies against Vibrio vulnificus RtxA1 elicit protective immunity through distinct mechanisms.

Authors:  Tae Hee Lee; Sun-Shin Cha; Chang-Seop Lee; Joon Haeng Rhee; Kyung Min Chung
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

2.  Comparative proteomic analysis reveals activation of mucosal innate immune signaling pathways during cholera.

Authors:  Crystal N Ellis; Regina C LaRocque; Taher Uddin; Bryan Krastins; Leslie M Mayo-Smith; David Sarracino; Elinor K Karlsson; Atiqur Rahman; Tahmina Shirin; Taufiqur R Bhuiyan; Fahima Chowdhury; Ashraful Islam Khan; Edward T Ryan; Stephen B Calderwood; Firdausi Qadri; Jason B Harris
Journal:  Infect Immun       Date:  2015-01-05       Impact factor: 3.441

3.  Phenotypic Analysis Reveals that the 2010 Haiti Cholera Epidemic Is Linked to a Hypervirulent Strain.

Authors:  Karla J F Satchell; Christopher J Jones; Jennifer Wong; Jessica Queen; Shivani Agarwal; Fitnat H Yildiz
Journal:  Infect Immun       Date:  2016-08-19       Impact factor: 3.441

4.  Antagonism toward the intestinal microbiota and its effect on Vibrio cholerae virulence.

Authors:  Wenjing Zhao; Florence Caro; William Robins; John J Mekalanos
Journal:  Science       Date:  2018-01-12       Impact factor: 47.728

5.  Comparative biochemical characterization of three exolytic oligoalginate lyases from Vibrio splendidus reveals complementary substrate scope, temperature, and pH adaptations.

Authors:  Sujit Sadashiv Jagtap; Jan-Hendrik Hehemann; Martin F Polz; Jung-Kul Lee; Huimin Zhao
Journal:  Appl Environ Microbiol       Date:  2014-05-02       Impact factor: 4.792

6.  Neutrophil-Associated Responses to Vibrio cholerae Infection in a Natural Host Model.

Authors:  Dustin Farr; Dhrubajyoti Nag; Walter J Chazin; Simone Harrison; Ryan Thummel; Xixia Luo; Saumya Raychaudhuri; Jeffrey H Withey
Journal:  Infect Immun       Date:  2022-01-24       Impact factor: 3.609

7.  The Vibrio cholerae MARTX toxin silences the inflammatory response to cytoskeletal damage before inducing actin cytoskeleton collapse.

Authors:  Patrick J Woida; Karla J F Satchell
Journal:  Sci Signal       Date:  2020-01-14       Impact factor: 9.517

8.  Rapid CD8+ Function Is Critical for Protection of Neonatal Mice from an Extracellular Bacterial Enteropathogen.

Authors:  David T Siefker; Becky Adkins
Journal:  Front Pediatr       Date:  2017-01-09       Impact factor: 3.418

Review 9.  Vibrio cholerae at the Intersection of Immunity and the Microbiome.

Authors:  Ana A Weil; Rachel L Becker; Jason B Harris
Journal:  mSphere       Date:  2019-11-27       Impact factor: 4.389

10.  Aerobic Metabolism in Vibrio cholerae Is Required for Population Expansion during Infection.

Authors:  Andrew J Van Alst; Victor J DiRita
Journal:  mBio       Date:  2020-09-01       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.